Logo startup Celluris

About This Project

Celluris is the first company in Latin America to develop personalized treatment for oncologic patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells that start to recognize the tumor as a target, fighting it in a precise way.


BUSINESS MODEL: B2C for oncologic patients


PRODUCT: In development


STAGE: Validation


For further information, please contact us.

Back to Investors page

Receba nossos materiais

Para receber informações e novidades sobre o BiotechTown, escolha o assunto e cadastre seu e-mail.